Holen Sie sich die Stockscreener-App
100.33
1.33%
1.32
Handel nachbörslich:
100.35
0.02
+0.02%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025) - ts2.tech
Merck & Co (MRK) Analyst Ratings Update: Morgan Stanley Raises P - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Given New $102.00 Price Target at Morgan Stanley - MarketBeat
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 - The Motley Fool
Morgan Stanley Adjusts Merck & Co. PT to $102 From $100, Maintains Equalweight Rating - marketscreener.com
Merck Receives Positive EU CHMP Opinion For Expanded Use Of WINREVAIR In Adults With Pulmonary Arterial Hypertension - TradingView
Peapack Gladstone Financial Corp Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Sei Investments Co. - MarketBeat
Canada Pension Plan Investment Board Has $287.91 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main - MarketBeat
Alliancebernstein L.P. Sells 1,382,219 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Up 1.4%Should You Buy? - MarketBeat
Merck & Co., Inc. $MRK Stock Position Decreased by The Manufacturers Life Insurance Company - MarketBeat
Investment House LLC Sells 75,437 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. (MRK) gets conditional approval for EXZOLT CATTLE-CA1 - MSN
Merck & Co., (MRK) Gets Conditional Approval For EXZOLT CATTLE-CA1 - Insider Monkey
Is It Smart To Buy Merck & Co., Inc. (NYSE:MRK) Before It Goes Ex-Dividend? - simplywall.st
NewEdge Advisors LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
BNP Paribas Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
EDENTREE ASSET MANAGEMENT Ltd Purchases 15,000 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Unusual Options Activity - Benzinga
Guggenheim lifts PT on Merck & Co. (MRK) to $122 from $104 - MSN
Guggenheim Lifts PT on Merck & Co. (MRK) to $122 From $104 - Insider Monkey
Merck & Co., Inc. $MRK Shares Sold by Intact Investment Management Inc. - MarketBeat
Stamos Capital Partners L.P. Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
HSBC Adjusts Price Target on Merck & Co. to $120 From $100, Maintains Buy Rating - marketscreener.com
Merck (NYSE:MRK) Could Be A Buy For Its Upcoming Dividend - Yahoo Finance
Diadema Partners LP Acquires New Shares in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 2%Here's What Happened - MarketBeat
Investment Management Corp of Ontario Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Cut by State Street Corp - MarketBeat
Fayez Sarofim & Co Sells 296,666 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Boosted by Daiwa Securities Group Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Federated Hermes Inc. - MarketBeat
Axa S.A. Sells 13,668 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Sees Unusually High Options Volume (NYSE:MRK) - MarketBeat
Natixis Sells 852,150 Shares of Merck & Co., Inc. $MRK - MarketBeat
SVB Wealth LLC Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Ossiam - MarketBeat
Gabelli Funds LLC Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Jim Cramer on Merck: “The People Who Run This Company Are Not Idiots” - Yahoo Finance
California Public Employees Retirement System Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Goldman Sachs Reduced the PT on Merck & Co., Inc. (MRK), Kept a Buy Rating - MSN
48,678 Shares in Merck & Co., Inc. $MRK Acquired by Stenger Family Office LLC - MarketBeat
Cheviot Value Management LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Cresset Asset Management LLC Has $21.75 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Epoch Investment Partners Inc. Has $57.05 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Brown Advisory Inc. Sells 22,392 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck (NYSE:MRK) S&P 500 Companies Power Drug Progress - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 1.1%Here's Why - MarketBeat
Trek Financial LLC Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
M Holdings Securities Inc. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kennedy Capital Management LLC - MarketBeat
Guggenheim Adjusts Price Target on Merck & Co. to $122 From $104, Maintains Buy Rating - marketscreener.com
Amundi Buys 3,454,941 Shares of Merck & Co., Inc. $MRK - MarketBeat
Beutel Goodman & Co Ltd. Acquires 679,339 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.4%What's Next? - MarketBeat
Merck & Co. Closes $7 Billion Notes Offering - TipRanks
Merck & Co., Inc. (MRK) Stock: Gains FDA Nod for New Cattle Antiparasitic - CoinCentral
Scotiabank Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment - pharmiweb.com
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis) - Business Wire
0.15%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):